Navigation Links
Accumed Research Associates Launches Official Website
Date:3/31/2010

www.AccumedResearch.com Aims to Increase Local Enrollment of Medical Clinical Trials

(PRWEB) March 29, 2010 -- In a move aimed at reaching out to a larger local patient population, leading clinical trial and patient care site Accumed Research Associates of Garden City, NY on long Island has launched its official website.

The website, http://www.AccumedResearch.com/, provides comprehensive information on all of the clinical trials conducted at the company’s Garden City, New York site on Long Island. The company conducts clinical trials or research studies to test the effects and safety of new investigational medications, medical treatments, or devices on patients with various clinical conditions.

Speaking about what motivated Accumed Research to build a presence on the World Wide Web, founder of the company Dr. Mitchell D. Efros, M.D., FACS, said, “We want people to know that there are some excellent options available for treatment of various conditions that might not be available to most patients whose doctors do not have the availability or access to clinical trials. Clinical trials afford us the opportunity to remain on the cutting edge of new technologies and treatments and offer this to our patients.” Dr Efros continued, “In many instances the patients receive their study related care and medication for free and are compensated for their time and travel as well. Our patients receive safe and compassionate care and we want people to know about these options."

Accumed Research is currently conducting clinical research study on several urologic conditions including enlarged prostate (BPH), incontinence or urinary urgency incontinence, overactive bladder (OAB), nocturia, erectile dysfunction, and cancer of prostate and bladder.

The NY clinical trial company was founded by Dr Efros in 2001. He is the Medical Director and Principal Investigator at Accumed Research Associates. Dr Efros, who graduated with honors from the New York Medical College in 1982, has vast experience in all areas of urology. A well-respected figure in the field of clinical research, Dr Efros has been a principal investigator in more than100 clinical trials. The company also has five affiliated full-time board certified urologists conducting trials, and assisting them are two nurse practitioners and a physician assistant, whom have many years of combined research experience.

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

About Accumed Research Associates (www.AccumedResearch.com)
Accumed Research Associates (http://www.AccumedResearch.com/) is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of urologic clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

Contact: Accumed Research Associates:
Tel: 1-888-746-2190
Email: Info(at)AccumedResearch(dot)com
www.AccumedResearch.com

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3798494.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. McMaster researcher leads development of promising drug for inflammation
2. European hematologist receives award to conduct research in US
3. Research shows why we forget to take our medicine, and what we can do about it
4. New Research Shows 'Kangaroo Mother Care' Reduces Newborn Deaths More than 50 Percent
5. Researchers identify potential new target for treating hepatitis C
6. Canadian research team awarded international grant for work on Indigenous peoples health
7. New ethical guidelines needed for dementia research
8. Sisters Helping Sisters: A New Lupus Research Study to Follow Sisters of Lupus Patients
9. Research confirms that some forms of massage help against low-back pain
10. Aderans Research Acquires Intercytex Assets
11. Researchers Identify 2 Genes Linked to Fatty Liver Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
Breaking Medicine Technology: